The structural features of PrPSc aggregates lead to the phosphorylation of tau proteins [47], which reflects the frequent coexistence of tau pathology in prion diseases, implying that similar pathogenic mechanisms may exist among diseases encompassing PrPSc deposition to tau aggregation. The gene discussed is MAPT; the disease is prion disease.